Product Development and Labeling

EAS’s strategic consulting service will provide solutions to companies confronting daunting product development and labeling issues by taking a holistic approach that considers a company’s marketing objectives and the current regulatory, compliance, and enforcement environment at the federal, state and local levels. The service is most often provided by a small team of expert consultants with complementary backgrounds.

Clients are guided through the various regulatory processes at each level of government including government affairs strategies, how to best effectuate policy changes and file official comments as necessary.

Our consultants help address questions such as: Should your company disclose GMO ingredients, create a “non-GMO” product line, or stay the course? What are the risks of self-defining “natural” foods including the risk of class action litigation challenging such claims? How can your company make undefined claims such as “Handcrafted” while minimizing risk from federal and state regulatory authorities and more?

Let EAS help develop proactive solutions for:



GMO Labeling



“Natural” Foods and Claims



Undefined Claims



New Threats Posed by FDA Warning Letters



FTC v. FDA



Trending Claims



Nutrition Facts Panel



Supplement Facts Panel



Competitive Challenges



Crisis Management



Long-Term Planning



Submissions Assistance



In-House Training

FDA Publishes 2026 Foods Program Guidance Agenda: What Industry Should Know

Building Food Safety Culture When No One Is Watching

Food safety culture is, at its core, about manners in motion – the everyday behaviors and small choices that add up to a safe, consistent, and trustworthy operation – and it works best when expectations are modeled from the top and lived by everyone on the floor. It grows through repetition: the same good habits practiced shift after shift until they become second nature.

Drug and Device Corner 2026 January

Bipartisan HEMP Act Aims to Create FDA Framework for Hemp-Derived Products

FDA Records Access Authority for Cosmetics: Draft Guidance Now Available

Durbin Introduces Legislation To Improve Transparency and Safety of Dietary Supplements

U.S. Senate Democratic Whip Dick Durbin has reintroduced the Dietary Supplement Listing Act, legislation aimed at improving transparency and safety in the dietary supplement market.

Artificial Intelligence: Quality Friend or Foe

Artificial intelligence is quickly finding its way into quality systems across pharmaceutical, medical device, food, and dietary supplement operations. While AI tools offer clear potential to improve efficiency, trend analysis, and decision-making, they also raise important questions about data integrity, validation, and regulatory oversight.